A COMPARATIVE EVALUATION OF THE HEALTH ECONOMIC OUTCOMES OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS WITH CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Mitri, G. [1 ]
Wittbrodt, E. T. [1 ]
Turpin, R. S. [1 ]
Costa, L. A. [2 ]
Schulman, K. [2 ]
机构：
[1] Takeda Pharmaceut Inc, Med Affairs, Deerfield, IL USA
[2] Outcomes Res Solut Inc, Shrewsbury, MA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1625
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0174
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [21] UPDATE ON COMPARATIVE CARDIOVASCULAR SAFETY OF FEBUXOSTAT VERSUS ALLOPURINOL AMONG PATIENTS WITH GOUT
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 385 - 385
  • [22] FEBUXOSTAT APPEARS EFFECTIVE AND SAFE IN GOUT PATIENTS WITH SEVERE CHRONIC KIDNEY DISEASE
    Quilis, N.
    Gil, S.
    Andres, M.
    Vela, P.
    Pascual, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 542 - 543
  • [23] Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease
    Alan Zelicoff
    Clinical Rheumatology, 2014, 33 : 1837 - 1837
  • [24] Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease
    Zelicoff, Alan
    CLINICAL RHEUMATOLOGY, 2014, 33 (12) : 1837 - 1837
  • [25] To Compare the Efficacy of Febuxostat Versus Allopurinol in patients with Hyperuricemia due to Chronic Kidney Disease
    Elahi, Wajeeha
    Syed, Ameen Zubair
    Das, Bhagwan
    Dayo, Bella
    Memon, Rafia
    Naz, Afreen
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 942 - 944
  • [26] Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis
    Hsu, Yun-Shiuan O.
    Wu, I-Wen
    Chang, Shang-Hung
    Lee, Cheng-Chia
    Tsai, Chung-Ying
    Lin, Chan-Yu
    Lin, Wan-Ting
    Huang, Yu-Tung
    Wu, Chao-Yi
    Kuo, George
    Hsiao, Chih-Yen
    Lin, Hsing-Lin
    Yang, Chih-Chao
    Yen, Tzung-Hai
    Chen, Yung-Chang
    Hung, Cheng-Chieh
    Tian, Ya-Chong
    Kuo, Chang-Fu
    Yang, Chih-Wei
    Anderson, Gerard F.
    Yang, Huang-Yu
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (05) : 1159 - 1169
  • [27] Liver Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease
    Lee, Jung Sun
    Hong, Seokchan
    Won, Jebum
    Kwon, Oh Chan
    Oh, Ji Sean
    Kim, Yong-Gil
    Lee, Chang Keun
    Yoo, Bin
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] Hepatic Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease
    Lee, Jung Sun
    Won, Jebum
    Kwon, Oh Chan
    Lee, Seung Soo
    Oh, Ji Seon
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (05) : 527 - 531
  • [29] EFFECT OF FEBUXOSTAT VERSUS ALLOPURINOL ON HYPERURICEMIA AND PROGRESSION OF CHRONIC KIDNEY DISEASE
    Nagaraju, Shankar Prasad
    Attur, Ravindra Prabhu
    Rangaswamy, Dharshan
    Rao, Indu
    Rao, Srikanth Prasad
    Kaza, Sindhu
    Shenoy, Srinivas
    Saraf, Karan
    Bhojaraja, Mohan
    Ramaswamy, Ashok
    Laxminarayana, Sindhura Lakshmi Koulmane
    Kosuru, Srinivas
    Parthasarathy, Rajeevalochana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [30] Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
    Nagaraju, Shankar Prasad
    Shenoy, Srinivas Vinayak
    Rao, Indu
    Prabhu, Ravindra Attur
    Rangaswamy, Dharshan
    Bhojaraja, Mohan V.
    Guddattu, Vasudeva
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (04) : 279 - 287
12345